VTR:NYE-Ventas Inc. (USD)

EQUITY | REIT - Healthcare Facilities | New York Stock Exchange

Last Closing

USD 62.86

Change

0.00 (0.00)%

Market Cap

USD 21.02B

Volume

2.49M

Analyst Target

USD 38.42
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Ventas Inc is a real estate investment trust. The Company has diversified portfolio of seniors housing and healthcare properties located throughout the United States, Canada and the United Kingdom.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-08 )

Largest Industry Peers for REIT - Healthcare Facilities

Symbol Name Price(Change) Market Cap
WELL Welltower Inc

N/A

USD 81.50B
DOC Healthpeak Properties Inc

N/A

USD 16.16B
CTRE CareTrust REIT Inc.

N/A

USD 5.63B
AHR American Healthcare REIT, Inc.

N/A

USD 4.00B
NHI National Health Investors Inc

N/A

USD 3.32B
LTC LTC Properties Inc

N/A

USD 1.56B
UHT Universal Health Realty Income..

N/A

USD 0.56B
CHCT Community Healthcare Trust Inc

N/A

USD 0.49B
GMRE-PA Global Medical REIT Inc

N/A

USD 0.41B
GMRE Global Medical REIT Inc

N/A

N/A

ETFs Containing VTR

BYRE Principal Exchange-Traded.. 8.53 % 0.00 %

N/A

USD 0.01B
WNEW:LSE WisdomTree New Economy Re.. 5.92 % 0.00 %

N/A

N/A
WTRE:LSE WisdomTree New Economy Re.. 5.92 % 0.00 %

N/A

N/A
WTRE WisdomTree New Economy Re.. 4.99 % 0.00 %

N/A

USD 0.02B
WNER:LSE WisdomTree New Economy Re.. 4.97 % 0.00 %

N/A

USD 0.81M
WTNR:LSE WisdomTree New Economy Re.. 4.97 % 0.00 %

N/A

USD 2.65M
WTRE:XETRA WisdomTree New Economy Re.. 4.69 % 0.00 %

N/A

USD 2.55M
WTER:XETRA WisdomTree New Economy Re.. 4.69 % 0.00 %

N/A

USD 3.43M
REZ iShares Residential and M.. 4.68 % 0.48 %

N/A

USD 1.24B
JPRE JPMorgan Realty Income ET.. 4.56 % 0.00 %

N/A

USD 0.38B
RSPR Invesco S&P 500® Equal.. 3.31 % 0.00 %

N/A

USD 0.12B
DJRE:AU SPDR Dow Jones Global Rea.. 2.20 % 0.00 %

N/A

USD 0.43B
TRET:F VanEck Vectors ETFs N.V. .. 2.08 % 0.00 %

N/A

USD 0.28B
TRET:SW VanEck Global Real Estate.. 2.08 % 0.00 %

N/A

USD 0.32B
RENT:AU 2.03 % 0.00 %

N/A

N/A
GLRA:LSE SPDR® Dow Jones Global R.. 1.72 % 0.00 %

N/A

USD 0.04B
GBRE:SW SPDR® Dow Jones Global R.. 1.72 % 0.00 %

N/A

USD 0.28B
GLRA:SW SPDR® Dow Jones Global R.. 1.72 % 0.00 %

N/A

USD 0.04B
REAI Tidal ETF Trust - Intelli.. 1.64 % 0.00 %

N/A

USD 3.92M
SPYD SPDR® Portfolio S&P 500 .. 1.40 % 0.08 %

N/A

USD 6.79B
ENG:PA BNP Paribas EASY ECPI Glo.. 1.12 % 0.00 %

N/A

USD 0.24B
XU61:F BNP Paribas Easy SICAV - .. 1.12 % 0.00 %

N/A

USD 0.24B
ENGUS:PA BNP Paribas Easy ECPI Glo.. 1.12 % 0.00 %

N/A

N/A
DRW 0.00 % 0.58 %

N/A

N/A
EWRE 0.00 % 0.40 %

N/A

N/A
OLD 0.00 % 0.50 %

N/A

N/A
HOMZ The Hoya Capital Housing .. 0.00 % 0.00 %

N/A

USD 0.05B
WREI 0.00 % 0.32 %

N/A

N/A
SPYJ:XETRA SPDR® Dow Jones Global R.. 0.00 % 0.00 %

N/A

USD 0.27B
TRET:XETRA VanEck Vectors ETFs N.V. .. 0.00 % 0.00 %

N/A

USD 0.28B
XU61:XETRA BNP Paribas EASY ECPI Glo.. 0.00 % 0.00 %

N/A

USD 0.27B
CGRE:CA CI Global REIT Private Po.. 0.00 % 0.00 %

N/A

CAD 0.06B
SPY2:XETRA SPDR® Dow Jones Global R.. 0.00 % 0.00 %

N/A

USD 0.27B
TREG:LSE VanEck Vectors ETFs N.V. .. 0.00 % 0.00 %

N/A

USD 0.32B
TRET:LSE VanEck Vectors ETFs N.V. .. 0.00 % 0.00 %

N/A

USD 0.32B
SPY2:F SSgA SPDR ETFs Europe I P.. 0.00 % 0.00 %

N/A

USD 0.27B

Market Performance

  Market Performance vs. Industry/Classification (REIT - Healthcare Facilities) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 26.12% 57% F 92% A
Dividend Return 1.81% 7% C- 42% F
Total Return 27.93% 57% F 92% A
Trailing 12 Months  
Capital Gain 48.32% 64% D 94% A
Dividend Return 4.25% 21% F 59% D-
Total Return 52.57% 64% D 94% A
Trailing 5 Years  
Capital Gain -12.65% 54% F 31% F
Dividend Return 13.93% 8% B- 52% F
Total Return 1.29% 46% F 31% F
Average Annual (5 Year Horizon)  
Capital Gain 4.51% 80% B- 55% F
Dividend Return 8.36% 80% B- 58% F
Total Return 3.85% 27% F 70% C-
Risk Return Profile  
Volatility (Standard Deviation) 31.76% 7% C- 32% F
Risk Adjusted Return 26.32% 67% D+ 46% F
Market Capitalization 21.02B 90% A- 92% A

Key Financial Ratios

  Ratio vs. Industry/Classification (REIT - Healthcare Facilities) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 36.00 11% 0%
Price/Book Ratio 2.67 33% 33%
Price / Cash Flow Ratio 21.48 40% 16%
Price/Free Cash Flow Ratio 19.86 33% 18%
Management Effectiveness  
Return on Equity -1.44% 20% 29%
Return on Invested Capital 2.94% 40% 38%
Return on Assets 1.67% 30% 45%
Debt to Equity Ratio 142.04% 10% 23%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector